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PERK-mediated translational 
control is required for collagen 
secretion in chondrocytes
Satoshi Hisanaga1,4, Masato Miyake1,2,3, Shusuke Taniuchi1,2, Miho Oyadomari1,2, Masatoshi 
Morimoto1, Ryosuke Sato1, Jun Hirose5,6, Hiroshi Mizuta4 & Seiichi Oyadomari1,2,3
As chondrocytes are highly secretory and they experience a variety of stresses, physiological 
unfolded protein response (UPR) signalling is essential for extracellular matrix (ECM) secretion and 
chondrogenesis. In the three branches of the UPR pathway, PERK governs the translational attenuation 
and transcriptional upregulation of amino acid and redox metabolism and induction of apoptosis. It 
was previously demonstrated that a defect of the PERK branch of the UPR signalling pathway causes 
the accumulation of unfolded proteins, leading to cell death without perturbing endoplasmic reticulum 
(ER)-to-Golgi transport in pancreatic β cells. However, little is known about the role of PERK in 
chondrocytes. In this study, we found that PERK signalling is activated in chondrocytes, and inhibition 
of PERK reduces collagen secretion despite causing excessive collagen synthesis in the ER. Perk−/− 
mice displayed reduced collagen in articular cartilage but no differences in chondrocyte proliferation 
or apoptosis compared to the findings in wild-type mice. PERK inhibition increases misfolded protein 
levels in the ER, which largely hinder ER-to-Golgi transport. These results suggest that the translational 
control mediated by PERK is a critical determinant of ECM secretion in chondrocytes.
Cartilage is characterised by a structurally arranged extracellular matrix (ECM) composed of collagen and 
non-collagenous proteins such as proteoglycans1,2. The chondrocyte is the sole resident cell type in articular car-
tilage, and this highly specialised cell plays a crucial role in ECM maintenance. As articular cartilage is avascular, 
chondrocytes exist at low oxygen tension and under limited nutrient conditions. For example, oxygen tension 
ranges from 1% in the deep layers of articular cartilage to approximately 6% at the joint surface and less than 
7% in synovial fluid3,4. The glucose concentration surrounding chondrocytes within articular cartilage has been 
estimated to be 1 mM or lower, versus 4–6 mM in synovial fluid5. ECM production in articular chondrocytes is 
affected by its microenvironment, which, in return, affects the mechanical resilience of cartilage. Reduced ECM 
content is linked to the progression of degenerative joint diseases such as osteoarthritis (OA).
Secreted and membrane proteins are folded and assembled in the endoplasmic reticulum (ER) before trans-
port to the extracellular space or other cellular compartments. Poorly folded proteins are retained in the ER and 
targeted for degradation, and this ER protein quality control mechanism can be overwhelmed by various insults, 
such as hypoxia or low nutrients, resulting in ER stress. To alleviate ER stress, cells activate the so-called unfolded 
protein response (UPR). Under adaptive conditions, the UPR induces attenuation of protein synthesis to reduce 
the ER load via PERK signalling, inducing ER chaperones to assist protein folding mainly via ATF6 signalling 
and activating ER-associated degradation to eliminate misfolded proteins mainly via IRE1 signalling6,7. However, 
when the stress exceeds the capacity of the ER homeostatic machinery, cells undergo apoptosis8.
As chondrocytes are highly secretory and they experience a variety of stresses, physiological UPR signalling 
appears essential for ECM secretion and chondrogenesis9–11. The importance of each UPR signalling branch for 
1Division of Molecular Biology, Institute for Genome Research, Institute of Advanced Medical Sciences, Tokushima 
University, Tokushima, 770-8503, Japan. 2Department of Molecular Research, Diabetes Therapeutics and Research 
Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, 770-8503, Japan. 3Fujii Memorial 
Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, 770-8503, 
Japan. 4Department of Orthopaedic Surgery, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, 
Kumamoto, 860-8556, Japan. 5Department of Orthopaedic Surgery, Kumamoto University Hospital, 1-1-1 Honjo, 
Chuo-ku, Kumamoto, 860-8556, Japan. 6Present address: Department of Medical Informatics, Graduate School 
of Biomedical Sciences, Tokushima University, Tokushima, 770-8503, Japan. Correspondence and requests for 
materials should be addressed to S.O. (email: oyadomar@tokushima-u.ac.jp)
Received: 16 May 2017
Accepted: 20 December 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2ScIenTIFIc REPORTS |  (2018) 8:773  | DOI:10.1038/s41598-017-19052-9
Figure 1. Activation of the PERK pathway upon the chondrogenic differentiation of ATDC5 cells in response 
to insulin. (A) Representative alcian blue staining and RT-qPCR analysis of aggrecan (Acan), type 2A1 collagen 
(Col2a1) expression in ATDC5 cells at differentiation days 1 (undifferentiated) and 14 (differentiated). 
ATDC5 cells were induced to differentiate into chondrocytes with 10 μg/ml insulin or 300 ng/ml BMP. Data 
are presented as the mean fold change ± SD in differentiated cells versus that in undifferentiated cells (n = 4 
technical replicates, **P < 0.01). Scale bar, 10 mm. (B) RT-qPCR analysis of Atf4, Gadd34, Chop, Xbp1s, 
Edem, Erdj4, Grp78, Grp94, Herp and 18 s expression in undifferentiated or differentiated ATDC5 cells. 
The mRNA levels were normalised to those of β-actin. Data are presented as the mean fold change ± SD in 
differentiated cells versus that in undifferentiated cells (n = 4 technical replicates, *P < 0.05, **P < 0.01). (C) 
Representative immunoblots and quantification of phosphorylated PERK, phosphorylated eIF2α, ATF4, CHOP, 
XBP1s, GRP94, GRP78 and ACTB in undifferentiated or differentiated ATDC5 cells. The protein levels were 
normalised to those of ACTB. Data are presented as the mean fold change ± SD in differentiated cells versus that 
in undifferentiated cells (n = 4 technical replicates, **P < 0.01). (D) Representative fluorescence micrographs of 
CMV::EGFP and AARE::EGFP ATF4 reporter ATDC5 cells on the indicated day after insulin stimulation. The 
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ECM secretion and chondrogenesis is apparent from gene targeting studies12. Activation of IRE1 pathway such 
as IRE1 phosphorylation and IRE1’s downstream target XBP1 splicing was observed in differentiating chondro-
cytes12. Cartilage-specific XBP1 knockout mice displayed a chondrodysplasia involving dysregulated chondrocyte 
proliferation and growth plate hypertrophic zone shortening, indicating roles of XBP1 in regulating chondro-
cyte proliferation and cartilage maturation13. Although ATF6 knockout mice have no defect on skeletal develop-
ment14, ablation of Creb3l2, a ATF6 homology preferentially expressed in chondrocytes exhibited a short limbs 
and reduced cartilage matrix15. The chondrocytes of Creb3l2 knockout mice displayed a delayed expression of 
differentiation markers and sever ER stress with the accumulation of ECM aggregates in the ER, indicating that 
Creb3l2 is critical for chondrocyte differentiation and ECM transport from the ER-to-Golgi16. PERK knockout 
mice are defective in both membranous and endochondral ossification and growth retardation17,18. Mice with 
cartilage-specific knockout of ATF4, which is a downstream transcription factor of PERK signalling, also dis-
played a short stature and delayed endochondral ossification19. Furthermore, PERK-deficient osteoblasts showed 
impaired osteoblast differentiation and compromised trafficking and secretion of type I collagen and abnormal 
retention of procollagen I in the ER20. However, the contribution of PERK to chondrocyte differentiation and 
ECM secretion has not been extensively investigated.
As evidenced by the severe chondrodysplasia of these UPR-defective mice, UPR signalling is essential for 
maintaining chondrocyte homeostasis. We previously reported that ER stress is induced in chondrocytes from 
OA mouse models21 and human patients22. We also uncovered that reducing ER stress-mediated apoptosis mit-
igates OA progression in an OA mouse model23. Although the role of UPR signalling on chondrocyte death has 
been investigated, it is unknown whether the UPR is involved in decreased ECM secretion in the presence of 
cartilage disorders. In this study, we demonstrate that inhibition of PERK decreases collagen secretion without 
affecting cell proliferation and death. Our finding indicates that the translational control regulated by PERK is 
required for collagen secretion in chondrocytes.
Results
Activation of PERK signalling occurs during chondrogenic differentiation in ATDC5 cells. As 
chondrocytes secrete abundant ECM proteins, ER stress has been implicated in chondrocyte proliferation, dif-
ferentiation and hypertrophy16. First, we verified whether the UPR is activated during the chondrogenic differ-
entiation of the mouse embryonal carcinoma-derived cell line ATDC5. ATDC5 provides an excellent in vitro 
model that exhibits chondrogenic differentiation by adding BMP2 or insulin24. In presence of BMP2 or insulin 
for 14 days, undifferentiated ATDC5 cells converted into chondrogenic cells which were strongly stained with 
alcian blue, and exhibited strong induction of type 2A collagen (Col2a1) and aggrecan (Acan) mRNA (Fig. 1A). 
As insulin induced chondrogenic conversion as same as BMP2, we used insulin for chondrogenic differentiation 
in subsequent experiments. Next, we examined whether UPR downstream target genes were induced in the dif-
ferentiated ATDC5 cells via RT-qPCR analysis. The expression of PERK pathway downstream target genes such 
as Atf4, Gadd34 and Chop was increased by 2.7-, 5.6- and 12.6-fold, respectively, in the differentiated ATDC5 
cells (Fig. 1B). Similar to PERK pathway activation, the expression of IRE1 or ATF6 pathway downstream genes 
such as the spliced form of Xbp1 (Xbp1s), Edem, Erdj4, Grp78, Grp94 and Herp was also increased by 7.8-, 1.8-, 
4.2-, 3.6-, 1.7- and 2.4-fold, respectively, in the differentiated ATDC5 cells (Fig. 1B). Whereas, expression of 
housekeeping gene 18 S rRNA was not affected during chondrogenic differentiation. In addition to mRNA levels, 
the protein levels of UPR markers were also determined. The levels of phosphorylated PERK and eIF2α were 
increased by 1.6- and 2.8-fold in the differentiated ATDC5 cells, respectively, and the expression of ATF4 and 
CHOP was also increased by 2.2- and 3.5-fold, respectively, indicating PERK pathway activation (Fig. 1C). The 
expression of XBP1s and GRP78 was increased by 2.2- and 1.5-fold, respectively, in the differentiated ATDC5 
cells (Fig. 1C). Thus, activation of the IRE1 and ATF6 pathways was observed, but the PERK pathway appeared 
to be more strongly activated in the differentiated ATDC5 cells than the other two branches of the UPR pathway. 
PERK-dependent UPR target genes are largely known to be regulated by ATF425,26. Therefore, we monitored ATF4 
activation using a reporter in which GFP was bound to the amino acid response element (AARE), which is the 
response sequence of ATF4. The GFP intensity of the CMV promoter-driven reporter remained unchanged, but 
the GFP intensity of the AARE reporter was increased as ATDC5 cells differentiated into chondrocytes (Fig. 1D). 
These results demonstrated that chondrocyte differentiation in ATDC5 cells activates the three branches of the 
UPR, among which the PERK pathway was most significantly activated.
Loss of PERK signalling increases intracellular COL2A1 levels but decreases extracellular 
COL2A1 levels in vitro. Analysis using PERK-deficient mice illustrated that PERK is essential for main-
taining the functions of secreted pancreatic β cells and osteoblasts18,27,28, but its role in chondrocytes has not been 
analysed. To detect whether the loss of PERK activity can affect the function of chondrocytes, we first analysed the 
effect of the specific PERK inhibitor GSK2606414 on the synthesis of COL2A1, which is a major ECM component 
secreted by chondrocytes. Exposure to 2 μM GSK2606414 decreased the basal phosphorylation level of eIF2α to 
approximately 10% of control levels in primary chondrocytes isolated from mice (Fig. 2A). Intracellular COL2A1 
expression was inversely correlated with eIF2α phosphorylation after PERK inhibition (Fig. 2A). To confirm the 
increased intracellular COL2A1 expression, we visualized PERK inhibitor-treated cells by staining COL2A1 and 
fluorescence intensity ratio of target (AARE::EGFP) to control (CMV::EGFP) was determined and normalized 
to undifferentiated cells. The schema represents control and ATF4 activity GFP reporter constructs containing 
25 tandem amino acid response elements (AAREs) (n = 4 technical replicates, **P < 0.01, NS = not significant). 
Scale bar, 200 μm.
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Figure 2. Type 2 A collagen (COL2A1) secretion was diminished by PERK inhibition, whereas intercellular 
COL2A1 expression was increased. (A) Representative immunoblots of phosphorylated eIF2α, cellular 
COL2A1 and ACTB in mouse primary chondrocyte treated with 2 μM PERK inhibitor for the indicated 
times. The protein levels were normalised to those of ACTB. Data are presented as the mean fold change ± SD 
compared to that in untreated cells (n = 4 technical replicates, **P < 0.01, NS = not significant). (B) 
Representative images of immunostaining for COL2A1 and KDEL (ER localization marker) in mouse primary 
chondrocytes treated with 2 μM PERK inhibitor for the indicated times. Relative fluorescence intensity 
was quantified in comparison to that of untreated cells and each group data consisted of images of 10 cells 
(n = 10 technical replicates, *P < 0.05). Scale bar, 200 μm. (C) Representative immunoblots of PERK, ACTB, 
phosphorylated eIF2α and secreted and cellular COL2A1 in collagen-secreting rat chondrosarcoma (RCS) 
cells stably expressing Cas9 and mock gRNA or three Perk-specific gRNAs. Data are presented as the mean fold 
change ± SD compared to that in mock gRNA-expressing cells (n = 4 technical replicates, **P < 0.01).  
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KDEL retrieval sequence as an ER localization marker. Immunocytochemistry revealed that COL2A1 expression 
gradually increased after 6 and 12 h of PERK inhibitor treatment, and the protein appeared to accumulate in the 
vacuole-like ER (Fig. 2B). To confirm the effect of PERK inhibition, we genetically disrupted the Perk gene using 
the CRISPR/Cas9 system with multiple Perk-specific gRNAs in collagen-secreting rat chondrosarcoma (RCS) 
cells. The expression of PERK and phosphorylated eIF2α was almost completely suppressed in Perk-mutated RCS 
cells (Fig. 2C). Consistent with the results of PERK inhibitor administration, intracellular COL2A1 expression 
was increased by nearly 2-fold, whereas extracellular COL2A1 secretion was decreased to 0.4-fold of control levels 
(Fig. 2C). Consistent with immunoblot data, ELISA analysis demonstrated that extracellular COL2A1 secretion 
decreased to 0.6-fold of the control levels in Perk-deleted RCS cells (Fig. 2D). To verify the observation from the 
Perk-deleted RCS cells, we examined extracellular COL2A1 secretion from the primary chondrocytes, which 
were isolated from wild-type or Perk−/− mice. Consistent with the RCS cell study, extracellular COL2A1 secre-
tion was decreased to 0.3-fold of control levels in the Perk−/− primary chondrocytes compared to the wild-type 
primary chondrocytes (Fig. 2E). Taken together, these results demonstrate that decreased PERK activity results 
in increased intracellular COL2A1 expression and decreased extracellular COL2A1 expression in chondrocytes.
Loss of PERK signalling decreases extracellular COL2A1 expression without reducing prolifer-
ation or increasing apoptosis in chondrocytes. To examine whether decreases in COL2A1 secretion 
in PERK-defective cultured chondrocytes are also observed in articular cartilage, we analysed Perk−/− mice. It is 
known that joint formation occurs at day 18.5 of embryogenesis in wild-type mice. Hence, we performed immu-
nostaining for COL2A1 in the growth plate of the tibia in wild-type and Perk−/− mice at 18.5 days postcoitum 
(dpc). COL2A1 expression was significantly decreased in the growth plate of Perk−/− mice compared with that in 
wild-type mice (Fig. 3A). Earlier studies on Perk−/− mice revealed that PERK deficiency leads to reduced prolif-
eration and increased apoptosis in insulin-secreting pancreatic β cells17,27,28. However, little is known regarding 
the impact of PERK deficiency in chondrocytes. Therefore, we investigated the effect of PERK deficiency on 
proliferation and apoptosis in chondrocytes using Perk−/− mice. To examine proliferation in Perk-deficient limbs, 
we measured bromodeoxyuridine (BrdU) incorporation into proliferating chondrocytes at 18.5 dpc. No signif-
icant difference was noted concerning the number of proliferating cells incorporating BrdU between wild-type 
and Perk−/− mice (Fig. 3B). Unlike pancreatic β cells, our result suggests that PERK deficiency does not affect 
chondrocyte proliferation. Next, we assessed chondrocyte apoptosis in the growth plate of the tibia at 18.5 dpc 
by TUNEL staining. We did not detect any TUNEL-positive cells in either wild-type or Perk−/− mice, suggesting 
that PERK deficiency does not induce apoptosis (Fig. 3C). Proliferation and apoptosis of chondrocytes may be 
regulated differently depending on their developmental stages. Therefore, we determined COL2A1 expression, 
BrdU incorporation, and TUNEL-positive apoptosis in the growth plate of the tibia at 16.5 dpc. Consistent with 
the observation at 18.5 dpc, reduced COL2A1 expression in Perk−/− mice, but no significant difference on chon-
drocyte proliferation and apoptosis between wild-type and Perk−/− mice were observed at 16.5 dpc (Supplemental 
Fig. 1). Because of our technical limitation, we could not examine that at the earlier developmental stage than 
16.5 dpc, but at least our observation is consistent with two different developmental stages. As cells in tissue are 
heterogeneous and their proliferation and apoptosis are not synchronised, it is possible to underestimate changes 
of proliferation or apoptosis under PERK-deficient conditions. Thus, we verified the effects of PERK deficiency 
on proliferation and apoptosis in cultured cells using a PERK inhibitor. Consistent with the results in Perk−/− 
mice, RCS cells treated with a PERK inhibitor exhibited no differences in cell proliferation and apoptosis from 
mock-treated cells (Fig. 3D,E). Thus, the data indicate that decreases in extracellular COL2A1 expression associ-
ated with the loss of PERK signalling do not lead to reduced proliferation or increased apoptosis in chondrocytes.
Inhibition of PERK disturbs ER protein folding homeostasis, which inhibits COL2A1 transport 
from the ER-to-Golgi in chondrocytes. Because PERK plays a role in attenuating translation in response 
to ER stress, inhibiting PERK function leads to excessive protein synthesis in the ER. In chondrocytes, ER over-
load caused by PERK dysfunction remarkably decreases COL2A1 secretion, and therefore, we sought to clarify 
the molecular mechanism. To investigate the mechanism by which COL2A1 secretion is suppressed, we exam-
ined changes in COL2A1 transport from the ER-to-Golgi using a PERK inhibitor. Several groups reported a pro-
cedure to synchronise ER-to-Golgi collagen transport29,30. Concretely, COL2A1 folding can be blocked at 40 °C, 
and unfolded or misfolded COL2A1 accumulates in the ER. COL2A1 accumulation can be rapidly reversed by 
reducing the temperature to 32 °C and adding ascorbic acid to the culture medium. To monitor COL2A1 trans-
port precisely, we performed a cycloheximide (CHX) chase combined with temperature-induced ER block release 
of COL2A1 (Fig. 4A). Immunostaining of mouse primary chondrocytes displayed CHX chase time-dependent 
colocalization (yellow) of COL2A1 (red) and the Golgi apparatus marker GM130 (green), demonstrating that 
ER-to-Golgi COL2A1 transport was nicely monitored using a CHX chase (Fig. 4B). The COL2A1 retention in 
the ER was reversed in the mock-treated mouse primary chondrocytes, but not in mouse primary chondrocytes 
treated with the PERK inhibitor at the 30 mins CHX chase point after shifting the temperature to 32 °C and add-
ing ascorbic acid (Fig. 4C,D). Consistent with the results in mouse primary chondrocytes treated with a PERK 
(D) Quantitative assessment of secreted COL2A1 in collagen-secreting RCS cells stably expressing Cas9 and 
mock gRNA or three Perk-specific gRNAs. Values were normalised by the total protein amount of the cells 
and shown as the mean ± SD (n = 4 technical replicates, *P < 0.05). (E) Quantitative assessment of secreted 
COL2A1 in primary chondrocytes derived from wild-type or Perk−/− mice at 18.5 days postcoitum (dpc). 
Values were normalised by the total protein amount of the cells and shown as the mean ± SD (n = 5 technical 
replicates, *P < 0.05).
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Figure 3. Type 2A collagen (COL2A1) expression was decreased in Perk−/− mice without a reduction of 
proliferation or increase in apoptosis in chondrocytes. (A) Representative fluorescence micrographs of 
immunohistochemistry for COL2A1 of tibial sections from wild-type or Perk−/− mice at 18.5 dpc. Scale bar, 
200 μm. Relative fluorescence intensity was presented as the mean fold change ± SD versus that of wild-type 
mice (n = 6 technical replicates, *P < 0.05). (B) Representative micrographs of immunohistochemistry for 
bromodeoxyuridine (BrdU) in tibial sections from wild-type or Perk−/− mice at 18.5 dpc. The sections were 
counterstained using hematoxylin. Scale bar, 200 μm. Ratio of BrdU-positive cells divided by the total number 
of cells was expressed as the mean ± SD (n = 5 technical replicates, NS = not significant). (C) Representative 
micrographs of TUNEL staining of tibial sections from wild-type or Perk−/− mice at 18.5 dpc. Scale bar, 
200 μm. (D) Representative micrographs of immunohistochemistry for BrdU of rat chondrosarcoma cells 
treated with mock inhibitor or 2 μM PERK inhibitor for 12 h. The cells were counterstained using Hoechest 
33258. Ratio of BrdU-positive cells divided by the total number of cells was expressed as the mean ± SD (n = 4 
technical replicates, NS = not significant). Scale bar, 200 μm. (E) Quantitative assessment of apoptotic DNA 
www.nature.com/scientificreports/
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inhibitor, primary chondrocytes from Perk−/− mice exhibited the COL2A1 retention in the ER at the 30 mins 
CHX chase point after shifting the temperature to 32 °C and adding ascorbic acid (Fig. 4E). These results suggest 
that the recovery of ER-to-Golgi transport of COL2A was largely delayed in PERK inhibition. We hypothesised 
that protein synthesis exceeding the folding capacity of the ER might compromise the folding of all newly syn-
thesised proteins in the ER and consequently delay ER-to-Golgi protein transport. To test the hypothesis, we 
evaluated the amount of misfolded proteins in the ER when chondrocytes were treated with a PERK inhibitor. 
Previously, we developed a method to estimate the amount of misfolded protein in the ER based on the level of 
the SDS-resistant high-molecular-weight (HMW) HSP47-containing complex in fibroblasts31 (Fig. 4F). In mouse 
primary chondrocytes, HSP47 levels in the PELLET fraction corresponding to misfolded protein in the ER were 
increased by PERK inhibitor treatment, whereas the levels of HSP47 in the INPUT fraction corresponding to 
total cellular HSP47 was unchanged (Fig. 4G). Altogether, these results support the concept that PERK inhibition 
disturbs ER protein folding homeostasis, which inhibits ER-to-Golgi COL2A1 transport in chondrocytes.
Discussion
OA is the most common chronic joint disease in the elderly, and it is characterised by the progressive destruction 
of articular cartilage, resulting in severe locomotor disability. Cartilage destruction is known to be caused by ECM 
degeneration and chondrocyte death. The mechanism of enhanced ECM degradation and increased chondrocyte 
apoptosis has been extensively studied, but little research has focused on reductions in ECM regeneration. Recent 
experimental data indicated that ER stress and the UPR contribute to chondrocyte apoptosis in cartilage patho-
physiology32,33, but their contribution to ECM secretion is not completely understood. In this study, we found 
that PERK signalling is activated in chondrocytes, and inhibition of PERK reduces collagen secretion despite 
inducing excessive collagen synthesis in the ER. Indeed, Perk−/− mice exhibited reduced collagen content in artic-
ular cartilage but no differences in chondrocyte proliferation or apoptosis compared to the findings in wild-type 
mice. PERK inhibition increases misfolded protein levels in the ER and hinders ER-to-Golgi protein transport. 
Misfolded proteins work in a dominant-negative manner. These results suggest that the translational control 
mediated by PERK is a critical determinant of chondrocyte pathophysiology (Fig. 5).
Among ECM proteins, collagen is of particular relevance to chondrogenesis and endochondral bone forma-
tion. Collagen undergoes translational modifications accompanied by its folding. For instance, hydroxylation of 
specific proline or lysine residues, O-glycosylation of specific hydroxylysine residues, and N-glycosylation of spe-
cific asparagine residues begin in the ER. Folding of the triple helix occurs in the ER together with the assembly of 
C-propeptides and formation of disulfide bonds. Consequently, disruption of collagen biosynthesis and assembly 
in the ER can occur at several steps, resulting in ER stress. The most significant examples were uncovered in stud-
ies of mutations in collagen-encoding genes34. Mutations in Col2A1 were reported to activate the UPR, leading 
to chondrocyte apoptosis and contributing to early OA35,36. In this study, we found that increased production of 
misfolded COL2A1 exerted a dominant effect by reducing collagen secretion. In addition, mutants of collagens 
and other ECM proteins such as cartilage oligomeric matrix protein (COMP), aggrecan (ACAN) and matrilin-3 
have been demonstrated to trigger ER stress and activate the UPR37–39. Thus, we speculated that the misfolded 
ECM proteins in chondrocytes are poorly secreted and largely retained in the ER, presumably via ER-associated 
degradation. As shown in Fig. 5, misfolded proteins cause secretion disorders, and further accumulation of mis-
folded proteins is believed to ultimately result in cell death. The diverging point of secretion disorders and cell 
death varies among cell types. In pancreatic β cells, PERK deletion did not disrupt ER-to-Golgi transport, but it 
increased cell death28. However, in chondrocytes, PERK deletion inhibited ER-to-Golgi transport without induc-
ing cell death. This cell-type-specific difference could be explained by cell-type-specific ER environments or ER 
client proteins. Interestingly, Li et al. demonstrated that silencing PERK reduced COL2A1 expression in human 
oseoarthiritic chondrocytes40, consisted with our observation of reduce COL2A1 secretion caused by the Perk 
deletion and the PERK activity inhibition. Li et al. also showed that silencing PERK resulted in an increase of 
COL1A1 expression in human osteoarthritic chondrocytes40. It is known that COL2A1 is reduced, while COL1A1 
is increased in the course of the progression of human OA41. Therefore, PERK might differentially regulate col-
lagen secretion depending on the type of collagen or on the different stages of OA and could be an important 
determinant of OA progression. In contrast, the complexity of protein folding and amount of newly synthesised 
proteins appear to be important determinants of PERK activation. Further investigations on the nature of PERK 
activaton and collagen-type-specific protein synthesis are required.
Concerning the regulation of ER protein homeostasis, mice lacking the essential autophagy-related gene 7 
(Atg7) in chondrocytes displayed accumulation of COL2 in the ER and lower levels of COL2 in cartilage com-
pared to the findings in wild-type mice29, suggesting that autophagy influences collagen secretion by controlling 
ER homeostasis. The reduced COL2 secretion phenotype of Atg7−/− mice due to inhibition of ER-to-Golgi trans-
port resembles that in cartilage from Perk−/− mice. Conversely, deletion of P58IPK, the cellular inhibitor of PKR 
and PERK, has been shown to cause bone changes and joint degeneration in mice42. Although, the the extent of 
ER stress and level of protein translation was not determined, upregulated phosphorylation of PKR and PERK was 
demonstrated in P58IPK–null mice42. It is not easy to reconcile why chondrodysplastic phenotypes were observed 
in both PERK-deleted and PERK-hyperactivated conditions. One explanation may suggest that PERK has 
another function besides collagen synthesis regulation, such as chondrocyte differentiation. Using a mouse model 
expressing misfolding collagen and lacking IRE1 pathway in chondrocytes, Cameron et al. demonstrate that 
fragmentation via nucleosomal DNA ELISA measuring the relative increase in primary chondrocytes treated 
with mock inhibitor or 2 μM PERK inhibitor for 24 h (n = 4 technical replicates, NS = not significant). Values 
were normalised by the total protein amount of the cells and shown as the mean ± SD.
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Figure 4. PERK inhibition led to accumulation of the high-molecular-weight type 2 A collagen (COL2A1), 
resulting in blockade of endoplasmic reticulum (ER)-to-Golgi transport. (A) Protocol for the procollagen 
transport assay. Mouse primary chondrocytes were treated with 2 μM PERK inhibitor for 12 h and exposed 
to a temperature of 40 °C for 3 h (accumulation in ER), followed by a temperature shift to 32 °C combined 
with exposure to 100 μg/ml cycloheximide and 50 μg/ml ascorbic acid for the indicated times (exit from ER). 
Procollagen transport was visualised by immunostaining. (B) Representative micrographs of immunostaining 
for Hoechest 33258, GM130 and COL2A1 in mouse primary chondrocytes after ER block release in the 
procollagen transport assay. Scale bar, 50 μm. (C) Representative micrographs of immunostaining for 
Hoechest 33258, GM130 and COL2A1 in mouse primary chondrocytes before and after ER block release in the 
procollagen transport assay. Mouse primary chondrocytes were pretreated with mock inhibitor or 2 μM PERK 
inhibitor for 12 h. Scale bar, 50 μm. (D) Quantification of transported COL2A1 in mock inhibitor- and PERK 
inhibitor-treated mouse primary chondrocytes. A scatter plot comparing mock inhibitor- and PERK inhibitor-
treated mouse primary chondrocytes regarding the ratio of Golgi-localised COL2A1 to total COL2A1 is shown 
and each group data consisted of images of 10 cells (n = 5 technical replicates, **P < 0.01). (E) Quantification 
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disruption of C/EBPβ, a regulator of chondrocyte differentiation, by CHOP, a transcription factor downstream of 
PERK that inhibits C/EBP proteins, and down-regulation of C/EBPβ transcriptional co-factors, GADD45β and 
RUNX243. These findings suggest that excess activation of PERK may contribute chondrodysplastic phenotype by 
dysregulation of chondrocyte dedifferentiation. Taken together, proper activation of PERK is crucial to maintain 
chondrocyte homeostasis. Our findings suggest that PERK may be a potential target for treating OA.
Methods
Mice. Perk−/− mice were previously described44. The experimental protocols involving animals were approved 
by the Animal Research Committee of Tokushima University, and all experiments were performed in accordance 
with the appropriate institutional guidelines.
Cell culture, transfection and transduction. ATDC5 and RCS cells were maintained in DMEM/F-12 
(Nacalai Tesque) supplemented with 5% fetal bovine serum (FBS, Gibco) and DMEM (Nacalai Tesque) supple-
mented with 10% FBS, respectively. For chondrocyte differentiation, confluent ATDC5 cells were cultured in 
maintenance medium supplemented with 10 μg/ml bovine insulin (Wako) which is refered to differentiation 
medium45. The culture medium was replaced daily. In some experiments, the cells were cultured in maintenance 
medium supplemented with 300 ng/ml human recombinant BMP-2(Miltenyi Biotec) instead of insulin. Primary 
chondrocytes were isolated from the limbs of 18.5 dpc embryonic or newborn mice as previously reported46. 
To inhibit the enzymatic activity of PERK, primary chondrocytes or RCS cells were treated with the highly 
specific PERK inhibitor GSK2606414 (Calbiochem)47. Transfection was performed using polyethylenimine 
(Polysciences) as described previously48. Lentiviral transduction was performed using a previously published 
protocol with modifications49.
Genome editing using the multiplex CRISPR/Cas9 assembly system. The specific gRNA sequences 
were selected using the CRISPR design tool (http://crispr.mit.edu/) and cloned into the pX330A-1 × 3 multiplex 
gRNA assembly vector (Addgene plasmid #58767)50 using the Golden Gate cloning method. Then, the multiplex 
gRNA cassette was replaced with the lentiviral vector LentiGuide-Puro (Addgene plasmid #52963). Stable expres-
sion of Cas9 and gRNAs was established via puromycin or blasticidin resistance using LentiCas9-Blast (Addgene 
plasmid #529632) following Zhang et al.’s protocol51.
RT-PCR analysis. Total RNA was subjected to RT using RiverTra Ace qPCR RT Master Mix with a gDNA 
Remover kit (TOYOBO Life Science) according to the manufacturer’s protocol. RT-PCR was performed using 
Power SYBR Green PCR Master Mix (Applied Biosystems). Real-time RT-PCR was performed using the 
StepOnePlus Real-Time PCR System (Applied Biosystems). The primer information is summarised in Table 1.
Immunoblot analysis. Cells were washed in ice-cold PBS and lysed in TNT buffer (50 mM Tris [pH 7.5], 
150 mM NaCl, 10% glycerol and 1% Triton X-100) with protease inhibitor cocktail (Nacalai Tesque), phosphatase 
inhibitor cocktail (Biotool) and 10 μM MG132 (Enzo Life). Immunoblot analysis was performed as previously 
described using Blocking One (Nacalai Tesque) or Blocking One-P (Nacalai Tesque) and WesternSure ECL 
Substrate (Li-Cor Biosciences). Protein was visualised using Ez-Capture II (ATTO Corp), and the band intensi-
ties were quantified using Image Studio software (Li-Cor Biosciences). The antibodies for immunoblotting were 
as follows: anti-phospho-Ser51-eIF2α (Cell Signaling Technology), anti-phospho-Ser51-Perk (Cell Signaling 
Technology), anti-ATF4 (Sigma Aldrich), anti-KDEL (Abcam), anti-β-actin (Abcam) and anti-COL2A1 
(Rockland). Anti-Chop and anti-Xbp1 were kindly gifted by Dr. David Ron (Cambridge Institute for Medical 
Research).
Immunohistochemistry. To detect extracellular COL2A1, immunohistochemistry was performed using 
standard protocols. Briefly, 16.5 or 18.5 dpc embryonic mouse tibiae were fixed in 4% paraformaldehyde and 
decalcified in Morse’s solution. After defatting using 70% ethanol extraction, decalcified tissues were embed-
ded in paraffin and sectioned into 5-μm slices. Deparaffinized sections were stained with rabbit anti-COL2A1 
(Rockland), and the primary antibody was visualised using anti-rabbit Alexa Fluor 488 (Molecular Probes). 
Fluorescence detection was performed using an FV10i laser-scanning confocal microscope (Olympus), and flu-
orescence intensities were measured using ImageJ. To detect intracellular COL2A1 expression, mouse primary 
chondrocytes were treated with 2 μM GSK2606414, fixed in 70% ethanol, and stained with rabbit anti-COL2A1 
and mouse anti-GM130 (BD Biosciences) at 4 °C for 12 h. Primary antibody was visualised using anti-mouse 
Alexa Fluor 488 and anti-rabbit Alexa Fluor 568 (Molecular Probes), and then, cells were stained with Hoechest 
of transported COL2A1 in primary chondrocytes derived from wild-type or Perk−/− mice at 18.5 dpc and 
each group data consisted of images of 10 cells (n = 5 technical replicates, **P < 0.01). (F) Protocol for high-
molecular-weight (HMW) detergent-resistant complex separation to measure COL2A1 folding. Mouse primary 
chondrocytes treated with 2 μM PERK inhibitor for the indicated times were lysed in lysis buffer, adjusted 
to 0.8% SDS, loaded on separation buffer and then ultracentrifuged at 100,000 × g for 45 min. The HMW 
detergent-resistant complex containing the collagen-specific chaperon HSP47 represents unfolded or misfolded 
COL2A1. (G) Representative immunoblots and quantification of HSP47 in SDS-resistant HMW complexes 
(PELLET) and total cell lysate (INPUT) from mouse primary chondrocytes treated with 2 μM PERK inhibitor 
for the indicated times. The protein levels of HSP47 in PELLET were normalised to the total HSP47 levels in 
INPUT and shown as the mean ± SD (n = 5 technical replicates, *P < 0.05).
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33258 (Invitrogen). Fluorescence detection was performed using a DMI 6000B fluorescence microscope (Leica) 
or FV10i laser-scanning confocal microscope, and fluorescence intensities were measured using ImageJ or 
Fluoview acquisition software (Olympus)49. To detect cell differentiation, ATDC5 cells were stained with alcian 
blue as previously described45.
ATF4 activation analysis. To monitor ATF4 activation, ATDC5 cells were transduced with lentiviral vec-
tors encoding an EGFP reporter gene driven by 25 repeats of the AARE or control EGFP lentiviral vectors. The 
green fluorescence of EGFP was visualised using a DMI 6000B fluorescence microscope, and fluorescence inten-
sities were measured using ImageJ.
Collagen secretion analysis. ER-to-Golgi protein trafficking was measured using a previously published 
protocol with modifications29,30. Briefly, mouse primary chondrocytes were synchronised by inhibiting the exit 
of cargoes from the ER by shifting the temperature to 40 °C for 3 h Then, the cargoes were permitted to synchro-
nously exit from the ER by adjusting the temperature to 32 °C combined with a 100 μg/ml CHX (Nacalai Tesque) 
chase in the presence of 50 μg/ml ascorbic acid (Sigma). At each CHX chase point, cells were fixed and subjected 
to immunohistochemistry. To measure extracellularly secreted collagen by immunoblot analysis, RCS cells were 
incubated in DMEM supplemented with 2% FBS for 4 h. Clarified culture supernatants from RCS cells were 
precipitated in the presence of 10% trichloroacetic acid. After washing in acetone, the precipitates were dissolved 
in urea loading buffer and then subjected to SDS-PAGE for immunoblot analysis. To measure extracellularly 
secreted collagen using ELISA, RCS cells or primary chondrocytes were incubated in Opti-MEM (Gibco) for 6 h 
or 12 h, and clarified culture supernatants from cells were directly subjected to secreted COL2A1 measurement 
using type II collagen detection ELISA kit (Chondrex).
No Oligo name Gene Sequence Purpose
1 mPerk.SP1 Perk aaggaccctatcctcctgctgcac Genotyping
2 mPerk.SP2 Perk gctaccggtggatgtggaatgtg Genotyping
3 mPerk.AP1 Perk cggagacagtacaagcgcagatga Genotyping
4 mCol2A1.SP1 Col2a1 gggtctcctgcctcctcctgc RT-PCR
5 mCol2A1.AP1 Col2a1 tcctttctgcccctttggccctaattttcg RT-PCR
6 mAcan.SP1 Acan gtcgggagcagcagtcacatctgagcag RT-PCR
7 mAcan.AP1 Acan ccattcgcctctctcatgccagatc RT-PCR
8 mActB.SP1 Actb ccgccctaggcaccagggtg RT-qPCR
9 mActB.AP1 Actb ggctggggtgttgaaggtctcaaa RT-qPCR
10 mAtf4.SP1 Atf4 atgatggcttggccagtg RT-qPCR
11 mAtf4.AP1 Atf4 ccattttctccaacatccaatc RT-qPCR
12 mGadd34.SP1 Gadd34 tcctctaaaagctcggaaggt RT-qPCR
13 mGadd34.AP1 Gadd34 caaagcggcttcgatctc RT-qPCR
14 mChop.SP1 Chop ccaccacacctgaaagcag RT-qPCR
15 mChop.AP1 Chop tcctcataccaggcttcca RT-qPCR
16 mXbp1s.SP1 Xbp1 gctgagtccgaatcaggtgcagg RT-qPCR
17 mXbp1s.AP1 Xbp1 tccttctgggtagacctctgggag RT-qPCR
18 mEdem1.SP1 Edem1 ggtcttcgaagctacgataagg RT-qPCR
19 mEdem1.AP1 Edem1 gggctgtttggaatcagttatta RT-qPCR
20 mErdj4.SP1 Erdj4 cacaaagatgccttttctaccg RT-qPCR
21 mErdj4.AP1 Erdj4 ttaaacttttcagcttaatgacgtg RT-qPCR
22 mGrp94.SP1 Grp94 acacactaggtcgtggaaca RT-qPCR
23 mGrp94.AP1 Grp94 gtctctgtcttgctactccaca RT-qPCR
24 mGrp78.SP1 Grp78 ctgaggcgtatttgggaaag RT-qPCR
25 mGrp78.Ap1 Grp78 tcatgacattcagtccagcaa RT-qPCR
26 mHerp.SP1 Herp acctgagccgagtctaccc RT-qPCR
27 mHerp.AP1 Herp aacagcagcttcccagaataaa RT-qPCR
28 m18s.SP1 18s gtaacccgttgaaccccatt RT-qPCR
29 m18s.AP1 18s ccatccaatcggtagtagcg RT-qPCR
30 rPerk-sgRNA.SP1 Perk catcggatacggcatttggc sgRNA
31 rPerk-sgRNA.AP1 Perk gccaaatgccgtatccgatg sgRNA
32 rPerk-sgRNA.SP2 Perk agatggacgaattgccgcac sgRNA
33 rPerk-sgRNA.AP2 Perk gtgcggcaattcgtccatct sgRNA
34 rPerk-sgRNA.SP3 Perk catacgggctcagtgcatat sgRNA
35 rPerk-sgRNA.AP3 Perk atatgcactgagcccgtatg sgRNA
Table 1. Primer list.
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HMW detergent-resistant complex detection. To estimate misfolded protein content in the ER, HMW 
detergent-resistant complex detection was performed using a previously published protocol with modifications31. 
Cultured cells were incubated for 5 min in ice-cold PBS containing 20 mM NEM and then collected by scraping 
in lysis buffer (0.5% Triton X-100, 20 mM HEPES [pH 7.5], 250 mM sucrose, 100 mM NaCl and 2.5 mM CaCl2) 
with protease inhibitors. Equal amounts of protein were adjusted to 0.8% SDS and then layered upon separation 
buffer (0.5% Triton X-100, 0.8% SDS, 20 mM HEPES [pH 7.5], and 20% glycerol) and centrifuged at 100,000 × g 
for 45 min. The resulting pellet was dissolved in urea loading buffer (9.6 M urea, 1.36% SDS, 40 mM Tris [pH 6.8], 
12% glycerol, 100 mM DTT and 0.002% bromophenol blue), boiled for 5 min and then subjected to SDS-PAGE 
for immunoblot analysis.
Proliferation assays. To evaluate chondrocyte proliferation in cartilage, pregnant females were injected 
at 16.5 or 18.5 dpc with 0.25 mg/g BrdU (TCI) 2 h before harvesting embryos. BrdU was detected using a BrdU 
staining kit (Abcam) based on the manufacturer’s protocol. To evaluate cultured RCS cells, cells were pulsed with 
20 mM BrdU for 30 min, fixed with 70% ethanol and stained with mouse anti-BrdU antibody (Biolegend) at 4 °C 
for 12 h. The primary antibody was visualised using anti-mouse Alexa Fluor 488, and then, cells were stained with 
Hoechest 33258. Fluorescence was visualised using a DMI 6000B fluorescence microscope.
Apoptosis detection assays. The ApopTag in situ apoptosis detection kit (Millipore) was used for TUNEL 
staining of mouse embryonic cartilage based on the manufacturer’s protocol, and TUNEL-positive cells were 
visualised using an Axioplan 2 fluorescence microscope (Zeiss). Apoptosis in the cultured chondrocytes was 
analysed using an ELISAPlus cell death detection kit (Roche Diagnostics).
Statistical analysis. Unless otherwise specified, data shown in each figure are representative of at least three 
biological replicates and all data were expressed as means ± standard deviations and analysed using Student’s 
t-test. P < 0.05 was defined as the threshold of significance.
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